Anatomic Stage IV Breast Cancer AJCC v8 Recruiting Phase 1 Trials for Alpelisib (DB12015)

IndicationStatusPhase
DBCOND0109665 (Anatomic Stage IV Breast Cancer AJCC v8)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03207529Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast CancerTreatment